BioArctic AB (publ) (BRCTF)
PNK: BRCTF
· Real-Time Price · USD
20.37
0.66 (3.35%)
At close: May 01, 2025, 2:28 PM
3.35% (1D)
| Bid | 19.71 |
| Market Cap | 1.8B |
| Revenue (ttm) | 257.35M |
| Net Income (ttm) | -177.08M |
| EPS (ttm) | -0.21 |
| PE Ratio (ttm) | -97 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 20.74 |
| Volume | 200 |
| Avg. Volume (20D) | 150 |
| Open | 20.37 |
| Previous Close | 19.71 |
| Day's Range | 20.37 - 20.37 |
| 52-Week Range | 12.94 - 24.80 |
| Beta | -0.67 |
About BRCTF
BioArctic AB (publ), a research-intensive biopharmaceutical company, develops biological drugs for patients with neurodegenerative disorders in Sweden. The company develops BAN2401, an immunotherapy, which is in Phase III clinical trials targeting the toxic amyloid-beta oligomers/protofibrils in Alzheimer's disease; and is in preclinical trials for treating Down's syndrome with dementia and traumatic brain injury, as well as BAN2401 Back-up, a di...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 29, 2022
Employees 107
Stock Exchange PNK
Ticker Symbol BRCTF
Website https://www.bioarctic.se